BMNDF (Biomind Labs) EBITDA Margin %: 0.00% (As of Mar. 2026)


BMNDF Biomind Labs Inc BMNDF
30 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Biomind Labs EBITDA Margin %?

Biomind Labs BMNDF 30 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates BMNDF with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 942 Biotechnology companies, Biomind Labs ranks worse than 106157.01% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Biomind Labs's EBITDA for the three months ended in Mar. 2026 was $-0.09 Mil. Biomind Labs's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Biomind Labs's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.

Biomind Labs  (OTCPK:BMNDF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Biomind Labs EBITDA Margin % Related Terms

Biomind Labs EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Biomind Labs's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomind Labs EBITDA Margin % Chart

Biomind Labs Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
0.00 0.00 0.00 0.00 0.00

Biomind Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BMNDF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Biomind Labs's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomind Labs EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomind Labs's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Biomind Labs's EBITDA Margin % falls into.


BMNDF
30GF Score
Biomind Labs Inc BMNDF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biomind Labs EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Biomind Labs's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.779/0
= %

Biomind Labs's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.086/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Biomind Labs (BMNDF) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biomind Labs and its competitors. According to the industry distribution chart, Biomind Labs ranks #999999 out of 942 companies in the Biotechnology industry.
Is Biomind Labs' EBITDA Margin % too high?
Biomind Labs' current EBITDA Margin % is 0.00%. Based on the distribution chart, Biomind Labs ranks #999999 out of 942 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Biomind Labs has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Biomind Labs' EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Biomind Labs ranks #999999 out of 942 companies for EBITDA Margin %. This places Biomind Labs in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biomind Labs and its competitors. Biomind Labs's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomind Labs stock overvalued right now?
Biomind Labs (BMNDF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Biomind Labs' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Biomind Labs (BMNDF), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomind Labs Business Description

Other Exchanges BMND:Canada
Address 701 West Georgia Street, Suite 515, Vancouver, BC, CAN, V7Y 1C6
Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. The firm is developing pharmaceutical solutions and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
30GF Score

Get the complete analysis for BMNDF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price